Tevogen Bio Holdings Inc.TVGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Trend
Above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
604.74%
↑ 379% above average
Average (3y)
126.18%
Historical baseline
Range
High:604.74%
Low:-100.00%
Volatility
558.5%
High variability
| Period | Value |
|---|---|
| 2024 | 604.74% |
| 2023 | 0.00% |
| 2022 | -100.00% |
| 2021 | 0.00% |